---
title: "The U.S. Food and Drug Administration has approved the simplification of patient monitoring requirem"
description: "The U.S. Food and Drug Administration has approved the simplification of patient monitoring requirements and the removal of the REMS program from the label of Bristol Myers Squibb's cell therapy"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/246345546.md"
published_at: "2025-06-27T02:09:14.000Z"
---

# The U.S. Food and Drug Administration has approved the simplification of patient monitoring requirem

> The U.S. Food and Drug Administration has approved the simplification of patient monitoring requirements and the removal of the REMS program from the label of Bristol Myers Squibb's cell therapy

The U.S. Food and Drug Administration has approved the simplification of patient monitoring requirements and the removal of the REMS program from Bristol Myers Squibb's cell therapy label

### Related Stocks

- [BMY.US - Bristol Myers Squibb](https://longbridge.com/en/quote/BMY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Pfizer Targets Real-World Myeloma Data in Taiwan With New Elranatamab Study | Pfizer Inc. (PFE) is launching a new observational study in Taiwan to evaluate the effectiveness of its multiple myeloma | [Link](https://longbridge.com/en/news/276252273.md) |
| ICICI Prudential Asset Management Co Ltd Grows Stock Holdings in Bristol Myers Squibb Company $BMY | ICICI Prudential Asset Management Co Ltd increased its stake in Bristol Myers Squibb Company (NYSE:BMY) by 85.8% in Q3,  | [Link](https://longbridge.com/en/news/276444619.md) |
| Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | Berkshire Hathaway Bought New York Times Stock in Q4. Should You Add NYT to Your Portfolio Too? | [Link](https://longbridge.com/en/news/276265837.md) |
| Hasbro Enters Into Fourth Amended Revolving Credit Agreement | Hasbro Inc :HASBRO INC - ENTERS INTO FOURTH AMENDED REVOLVING CREDIT AGREEMENT - SEC FILINGHASBRO INC - SECURES $1.1 BIL | [Link](https://longbridge.com/en/news/276493551.md) |
| What Analysts Are Saying About Bristol-Myers Squibb Stock | 16 analysts have evaluated Bristol-Myers Squibb (NYSE:BMY), revealing mixed sentiments with 4 bullish, 3 somewhat bullis | [Link](https://longbridge.com/en/news/276477307.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.